{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T12:20:40Z","timestamp":1786623640549,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["106-2320-B-038-051-MY3"],"award-info":[{"award-number":["106-2320-B-038-051-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["106-1200-008-110"],"award-info":[{"award-number":["106-1200-008-110"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.cbi.2018.06.006","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T10:50:03Z","timestamp":1528455003000},"page":"144-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["microRNA-199a\/b-5p enhance imatinib efficacy via repressing WNT2 signaling-mediated protective autophagy in imatinib-resistant chronic myeloid leukemia cells"],"prefix":"10.1016","volume":"291","author":[{"given":"Peng-Hsu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Jeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Hao","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7438-3556","authenticated-orcid":false,"given":"Ya-Ting","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Harn","family":"Anne Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ting","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chwen-Ming","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4696-3924","authenticated-orcid":false,"given":"Ku-Chung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2018.06.006_bib1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/300765a0","article-title":"A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia","volume":"300","author":"de Klein","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2018.06.006_bib2","first-page":"100","article-title":"Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative","volume":"56","author":"Buchdunger","year":"1996","journal-title":"Canc. Res."},{"key":"10.1016\/j.cbi.2018.06.006_bib3","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","article-title":"The development of imatinib as a therapeutic agent for chronic myeloid leukemia","volume":"105","author":"Deininger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2018.06.006_bib4","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/sj.leu.2402741","article-title":"Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy","volume":"16","author":"Hochhaus","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.cbi.2018.06.006_bib5","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1182\/blood-2005-05-2123","article-title":"BCR-ABL nuclear entrapment kills human CML cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B","volume":"107","author":"Aloisi","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2018.06.006_bib6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1182\/blood-2002-06-1756","article-title":"Presence of the BCR-ABL mutation Glu255Lys prior to STI571 (imatinib) treatment in patients with Ph+ acute lymphoblastic leukemia","volume":"102","author":"Hofmann","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2018.06.006_bib7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00277-006-0171-8","article-title":"Not all imatinib resistance in CML are BCR-ABL kinase domain mutations","volume":"85","author":"Wei","year":"2006","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.cbi.2018.06.006_bib8","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-11-0047","article-title":"The role of autophagy in cancer: therapeutic implications","volume":"10","author":"Yang","year":"2011","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.cbi.2018.06.006_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.biopha.2015.12.029","article-title":"Heme oxygenase-1 contributes to imatinib resistance by promoting autophagy in chronic myeloid leukemia through disrupting the mTOR signaling pathway","volume":"78","author":"Cao","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2018.06.006_bib10","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4161\/auto.5.7.9509","article-title":"Targeted therapies and autophagy: new insights from chronic myeloid leukemia","volume":"5","author":"Salomoni","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.cbi.2018.06.006_bib11","doi-asserted-by":"crossref","first-page":"e838","DOI":"10.1038\/cddis.2013.350","article-title":"Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment","volume":"4","author":"Sui","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2018.06.006_bib12","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3892\/or.2015.4456","article-title":"The roles of microRNAs in the pathogenesis and drug resistance of chronic myelogenous leukemia (Review)","volume":"35","author":"Di Stefano","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cbi.2018.06.006_bib13","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1182\/blood-2014-06-581926","article-title":"MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors","volume":"125","author":"Wang","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2018.06.006_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1476-4598-10-41","article-title":"Expression patterns of microRNAs associated with CML phases and their disease related targets","volume":"10","author":"Machova Polakova","year":"2011","journal-title":"Mol. Canc."},{"key":"10.1016\/j.cbi.2018.06.006_bib15","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/cas.13298","article-title":"Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer","volume":"108","author":"Koshizuka","year":"2017","journal-title":"Canc. Sci."},{"key":"10.1016\/j.cbi.2018.06.006_bib16","doi-asserted-by":"crossref","first-page":"67169","DOI":"10.18632\/oncotarget.18052","article-title":"MiR-199a\/b-5p inhibits hepatocellular carcinoma progression by post-transcriptionally suppressing ROCK1","volume":"8","author":"Zhan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cbi.2018.06.006_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.gene.2017.03.032","article-title":"miR-199a-5p and miR-495 target GRP78 within UPR pathway of lung cancer","volume":"620","author":"Ahmadi","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.cbi.2018.06.006_bib18","first-page":"1003","article-title":"Frequent up-regulation of WNT2 in primary gastric cancer and colorectal cancer","volume":"19","author":"Katoh","year":"2001","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cbi.2018.06.006_bib19","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1038\/sj.onc.1207844","article-title":"Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells","volume":"23","author":"You","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2018.06.006_bib20","doi-asserted-by":"crossref","first-page":"37257","DOI":"10.18632\/oncotarget.6133","article-title":"Wnt2 complements Wnt\/beta-catenin signaling in colorectal cancer","volume":"6","author":"Jung","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.cbi.2018.06.006_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1179\/102453311X12902908412039","article-title":"Imatinib induces autophagy through BECLIN-1 and ATG5 genes in chronic myeloid leukemia cells","volume":"16","author":"Can","year":"2011","journal-title":"Hematology"},{"key":"10.1016\/j.cbi.2018.06.006_bib22","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1182\/blood-2011-01-330621","article-title":"Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML","volume":"118","author":"Helgason","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2018.06.006_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gene.2014.03.049","article-title":"Down-regulation of miR-199b associated with imatinib drug resistance in 9q34.1 deleted BCR\/ABL positive CML patients","volume":"542","author":"Joshi","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.cbi.2018.06.006_bib24","doi-asserted-by":"crossref","first-page":"e35501","DOI":"10.1371\/journal.pone.0035501","article-title":"Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells","volume":"7","author":"Rokah","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2018.06.006_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2018.06.006_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cbi.2018.06.006_bib27","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood-2012-02-412890","article-title":"Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-beta-catenin signaling","volume":"121","author":"Zhang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2018.06.006_bib28","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.leukres.2015.02.013","article-title":"Celecoxib sensitizes imatinib-resistant K562 cells to imatinib by inhibiting MRP1-5, ABCA2 and ABCG2 transporters via Wnt and Ras signaling pathways","volume":"39","author":"Dharmapuri","year":"2015","journal-title":"Leuk. Res."},{"key":"10.1016\/j.cbi.2018.06.006_bib29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/1471-2407-12-303","article-title":"Wnt\/beta-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia","volume":"12","author":"Correa","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cbi.2018.06.006_bib30","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.3892\/ol.2016.5289","article-title":"Role of Wnt\/beta-catenin pathway in inducing autophagy and apoptosis in multiple myeloma cells","volume":"12","author":"Su","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.cbi.2018.06.006_bib31","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/emboj.2013.123","article-title":"Autolysosomal beta-catenin degradation regulates Wnt-autophagy-p62 crosstalk","volume":"32","author":"Petherick","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.cbi.2018.06.006_bib32","doi-asserted-by":"crossref","first-page":"38717","DOI":"10.18632\/oncotarget.16314","article-title":"Contributions of MET activation to BCR-ABL1 tyrosine kinase inhibitor resistance in chronic myeloid leukemia cells","volume":"8","author":"Tsubaki","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cbi.2018.06.006_bib33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ajh.23428","article-title":"Induction of autophagy by Imatinib sequesters Bcr-Abl in autophagosomes and down-regulates Bcr-Abl protein","volume":"88","author":"Elzinga","year":"2013","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cbi.2018.06.006_bib34","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/cdd.2008.107","article-title":"The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemias","volume":"15","author":"Kamitsuji","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cbi.2018.06.006_bib35","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1182\/blood-2012-01-402578","article-title":"Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide","volume":"120","author":"Goussetis","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2018.06.006_bib36","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/leu.2012.65","article-title":"Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells","volume":"26","author":"Yu","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.cbi.2018.06.006_bib37","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2174\/13894501113149990185","article-title":"Targeting miR-21 induces autophagy and chemosensitivity of leukemia cells","volume":"14","author":"Seca","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.cbi.2018.06.006_bib38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.blre.2016.11.003","article-title":"MicroRNA: defining a new niche in leukemia","volume":"31","author":"Fernandes","year":"2017","journal-title":"Blood Rev."},{"key":"10.1016\/j.cbi.2018.06.006_bib39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1476-4598-8-69","article-title":"MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations","volume":"8","author":"San Jose-Eneriz","year":"2009","journal-title":"Mol. Canc."},{"key":"10.1016\/j.cbi.2018.06.006_bib40","first-page":"1032","article-title":"Wnt2 promotes non-small cell lung cancer progression by activating WNT\/beta-catenin pathway","volume":"5","author":"Huang","year":"2015","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.cbi.2018.06.006_bib41","first-page":"537","article-title":"Activation of the Wnt pathway through Wnt2 promotes metastasis in pancreatic cancer","volume":"4","author":"Jiang","year":"2014","journal-title":"Am J Cancer Res"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718301364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718301364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:46:38Z","timestamp":1762112798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279718301364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":41,"alternative-id":["S0009279718301364"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2018.06.006","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"microRNA-199a\/b-5p enhance imatinib efficacy via repressing WNT2 signaling-mediated protective autophagy in imatinib-resistant chronic myeloid leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2018.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}